Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study

Cancer Treat Rep. 1987 Nov;71(11):1101-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anthracenes / adverse effects
  • Anthracenes / therapeutic use
  • Carcinoma, Hepatocellular / drug therapy*
  • Diagnosis-Related Groups
  • Drug Evaluation
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Anthracenes
  • bisantrene